ursolic acid has been researched along with Kahler Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, HJ; Choi, YJ; Lee, DY; Lee, G; Oh, S; Park, SJ; Shin, S; Song, GR; Song, GY | 1 |
| Aggarwal, BB; Ahn, KS; Bhutani, M; Chakraborty, A; Guha, S; Kadara, H; Nair, AS; Pathak, AK; Sethi, G | 1 |
2 other study(ies) available for ursolic acid and Kahler Disease
| Article | Year |
|---|---|
Root Bark of
Topics: Antineoplastic Agents, Phytogenic; beta Catenin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Humans; Morus; Multiple Myeloma; Plant Bark; Plant Roots; Proto-Oncogene Proteins c-myc; Triterpenes; Ursolic Acid; Wnt Signaling Pathway | 2021 |
Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Division; Cell Line, Tumor; Enzyme Activation; Humans; Immunohistochemistry; Multiple Myeloma; Oligonucleotide Probes; STAT3 Transcription Factor; Transfection; Triterpenes; Ursolic Acid | 2007 |